Peripheral Intravenous Catheter Market Size, Share, Growth, and Industry Analysis, By Type (Short PIVC,Ported PIVC,Non-ported PIVC,Integrated/Closed PIVC), By Application (Hospitals,Ambulatory surgical centres,Clinics,Home use,Others), Regional Insights and Forecast to 2035

Peripheral Intravenous Catheter Market Overview

Global Peripheral Intravenous Catheter market size is estimated at USD 1284.53 million in 2026, set to expand to USD 2457.8 million by 2035, growing at a CAGR of 7.5%.

Peripheral Intravenous Catheter Market demonstrates high clinical utilization with over 85% of hospitalized patients requiring intravenous access during treatment procedures. Approximately 72% of vascular access devices used globally are peripheral intravenous catheters, while 64% of emergency care settings rely on PIVC insertion within the first 30 minutes of patient admission. Peripheral Intravenous Catheter Market Report indicates that 61% of demand originates from acute care hospitals, with 48% linked to medication administration and 44% to fluid therapy. Peripheral Intravenous Catheter Market Analysis shows that 57% of devices used are safety-engineered, reducing needlestick injuries by 41% across healthcare facilities globally.

In the United States, the Peripheral Intravenous Catheter Market accounts for nearly 34% of global demand, with approximately 78% of hospitalized patients receiving at least one PIVC during their stay. Around 69% of intravenous therapies in U.S. hospitals utilize peripheral catheters, while 62% of emergency departments depend on rapid PIVC insertion for critical care. Peripheral Intravenous Catheter Industry Report highlights that 58% of healthcare facilities have adopted safety-engineered catheters, reducing complications in 46% of cases. Additionally, 53% of demand is driven by chronic disease management, while 49% is linked to outpatient and ambulatory care procedures across the country.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: 82% IV demand, 78% chronic diseases, 74% emergency care, 71% surgeries, 68% aging population globally.
• Major Market Restraint: 73% infections, 70% failures, 67% complications, 64% discomfort, 61% training, 58% replacements globally.
• Emerging Trends: 76% safety catheters, 72% antimicrobial coatings, 69% closed systems, 66% ultrasound insertion, 63% infection control.
• Regional Leadership: 35% North America, 27% Europe, 25% Asia-Pacific, 68% developed demand, 61% hospital usage globally.
• Competitive Landscape: 33% top players, 28% mid-tier, 22% regional, 69% innovation focus, 63% safety compliance globally.
• Market Segmentation: 42% short PIVC, 23% ported, 19% non-ported, 16% integrated, 61% hospitals globally.
• Recent Development: 75% safety launches, 71% antimicrobial tech, 68% approvals, 64% expansion, 61% training programs globally.

Peripheral Intravenous Catheter Market Trends

Peripheral Intravenous Catheter Market Trends indicate that nearly 76% of healthcare providers are adopting safety-engineered PIVCs, reducing needlestick injuries by 43% across hospital settings. Around 71% of new catheter designs incorporate antimicrobial coatings, lowering infection risks in 39% of clinical procedures. Peripheral Intravenous Catheter Market Insights reveal that 68% of hospitals are shifting toward integrated and closed catheter systems, improving patient safety outcomes by 36%.

Additionally, 65% of healthcare facilities are implementing ultrasound-guided insertion techniques, increasing first-attempt success rates by 41%. Approximately 62% of innovations focus on improving catheter dwell time, extending usability by 34% in long-term treatments. Peripheral Intravenous Catheter Market Outlook highlights that 59% of demand is moving toward disposable and single-use devices, while 56% of manufacturers are investing in ergonomic designs to enhance clinician efficiency. Furthermore, 52% of product development efforts target pediatric and geriatric patient segments, addressing specific needs across 47% of clinical applications globally.

Peripheral Intravenous Catheter Market Dynamics

DRIVER

"Increasing hospital admissions and intravenous therapy demand"

Peripheral Intravenous Catheter Market Growth is primarily driven by rising hospital admissions, with approximately 82% of inpatients requiring intravenous access during treatment. Around 77% of emergency cases depend on rapid PIVC insertion, while 73% of surgical procedures involve intravenous catheter usage. Peripheral Intravenous Catheter Market Analysis indicates that 69% of chronic disease patients require repeated IV therapies, increasing demand across 63% of healthcare facilities. Additionally, 66% of geriatric patients require continuous infusion therapy, while 61% of outpatient procedures involve PIVC usage. Approximately 58% of healthcare systems are expanding infrastructure, supporting increased catheter utilization in 54% of new facilities. Peripheral Intravenous Catheter Market Insights show that 51% of demand is directly linked to medication delivery and fluid administration, reinforcing the critical role of PIVCs in 48% of clinical workflows globally.

RESTRAINT

"High incidence of catheter-related complications"

Peripheral Intravenous Catheter Market faces restraints as nearly 73% of healthcare providers report catheter-related complications such as infections and phlebitis. Around 70% of PIVCs fail before completion of therapy, impacting patient outcomes in 57% of cases. Peripheral Intravenous Catheter Market Analysis highlights that 66% of complications arise from improper insertion techniques, while 62% are linked to prolonged catheter dwell time. Furthermore, 59% of healthcare facilities face challenges in maintaining infection control standards, increasing risk across 53% of procedures. Approximately 56% of clinicians report patient discomfort associated with catheter use, while 52% of institutions incur additional costs due to frequent catheter replacements. Peripheral Intravenous Catheter Market Outlook indicates that 49% of hospitals are investing in training programs to reduce complications, yet 45% continue to face operational challenges globally.

OPPORTUNITY

"Advancements in safety and antimicrobial technologies"

Peripheral Intravenous Catheter Market Opportunities are expanding as nearly 74% of manufacturers are developing safety-engineered devices to reduce needlestick injuries. Around 69% of innovations focus on antimicrobial coatings, decreasing infection rates in 42% of clinical settings. Peripheral Intravenous Catheter Market Research Report indicates that 65% of healthcare providers are adopting integrated catheter systems for improved safety. Additionally, 62% of investments are directed toward closed catheter systems, enhancing infection control across 56% of hospitals. Approximately 59% of product development focuses on improving catheter materials for longer dwell times, while 55% of research targets patient comfort and ease of insertion. Peripheral Intravenous Catheter Market Insights highlight that 52% of emerging opportunities are linked to advanced healthcare infrastructure, supporting adoption across 48% of global medical facilities.

CHALLENGE

"Skill dependency and variability in clinical practices"

Peripheral Intravenous Catheter Market faces challenges as nearly 68% of successful catheter insertions depend on clinician expertise, leading to variability in outcomes across 54% of procedures. Around 64% of healthcare facilities report inconsistencies in training standards, affecting performance in 51% of cases. Peripheral Intravenous Catheter Industry Analysis indicates that 60% of complications arise due to improper technique or lack of experience. Moreover, 57% of hospitals face staffing shortages, impacting catheter insertion efficiency in 49% of clinical settings. Approximately 55% of training programs require continuous updates, while 52% of healthcare providers struggle to standardize protocols. Peripheral Intravenous Catheter Market Outlook shows that 48% of institutions are investing in simulation-based training, yet 44% continue to face challenges in maintaining consistent quality of care across diverse healthcare environments.

Peripheral Intravenous Catheter Market Segmentation

Peripheral Intravenous Catheter Market segmentation indicates that nearly 42% of demand is driven by short PIVCs, followed by 23% ported PIVCs, 19% non-ported PIVCs, and 16% integrated or closed PIVCs. By application, hospitals dominate with approximately 61% share, followed by ambulatory surgical centres at 18%, clinics at 11%, home use at 6%, and others at 4%. Peripheral Intravenous Catheter Market Analysis shows that 68% of catheter usage is linked to medication administration, while 57% supports fluid therapy and 49% supports blood sampling. Additionally, 53% of healthcare providers prioritize safety-engineered devices, while 47% focus on infection prevention technologies.

Download FREE Sample to learn more about this report.

By Type

Short PIVC: Short PIVCs account for approximately 42% of the Peripheral Intravenous Catheter Market Share, driven by 74% usage in emergency and acute care settings. Around 69% of hospital admissions involve short PIVC insertion within the first 24 hours, supporting rapid treatment initiation in 63% of cases. Peripheral Intravenous Catheter Market Insights indicate that 61% of short PIVCs are used for short-term therapies lasting less than 96 hours. Additionally, 58% of clinicians prefer short PIVCs due to ease of insertion and lower procedural time, while 54% of demand originates from high-volume hospital environments. Approximately 51% of innovations in this segment focus on improving catheter material and flexibility, reducing failure rates by 43%. Peripheral Intravenous Catheter Market Trends show that 48% of short PIVCs now include safety features, supporting adoption across 45% of healthcare facilities globally.

Ported PIVC: Ported PIVCs represent nearly 23% of the Peripheral Intravenous Catheter Market Share, supported by 66% usage in multi-drug administration scenarios. Around 62% of healthcare providers prefer ported catheters for simultaneous medication delivery, improving workflow efficiency in 57% of clinical procedures. Peripheral Intravenous Catheter Market Analysis shows that 59% of ported PIVCs are used in critical care units and surgical departments. Furthermore, 55% of manufacturers are focusing on enhancing port design to reduce contamination risks, while 52% of innovations target improved sealing mechanisms. Approximately 49% of demand is driven by complex treatment protocols, and 46% of healthcare facilities prioritize ported systems for reducing repeated needle insertions. Peripheral Intravenous Catheter Market Outlook highlights that 43% of growth in this segment is linked to increasing multi-drug therapy requirements globally.

Non-ported PIVC: Non-ported PIVCs account for approximately 19% of the Peripheral Intravenous Catheter Market Share, with 64% of usage in basic fluid administration and medication delivery. Around 60% of healthcare facilities prefer non-ported catheters for cost-effective treatment options, particularly in 55% of developing regions. Peripheral Intravenous Catheter Market Insights indicate that 57% of non-ported PIVCs are used in routine clinical procedures. Additionally, 53% of demand is driven by simplicity and ease of use, while 49% of healthcare providers rely on these devices for low-risk applications. Approximately 46% of manufacturers focus on improving material quality to enhance durability, and 43% of innovations aim to reduce insertion-related complications. Peripheral Intravenous Catheter Market Trends show that 41% of non-ported PIVCs are used in outpatient settings, supporting widespread adoption across 38% of healthcare facilities globally.

Integrated/Closed PIVC: Integrated or closed PIVCs hold nearly 16% of the Peripheral Intravenous Catheter Market Share, supported by 68% adoption in infection-sensitive environments such as intensive care units. Around 63% of hospitals prefer integrated systems to minimize contamination risks, reducing infection rates in 44% of cases. Peripheral Intravenous Catheter Market Analysis shows that 60% of innovations in this segment focus on closed system designs. Furthermore, 56% of healthcare providers prioritize integrated PIVCs for enhanced patient safety, while 52% of demand originates from developed healthcare systems. Approximately 49% of manufacturers are investing in antimicrobial coatings, and 46% of product development efforts target improved catheter dwell time. Peripheral Intravenous Catheter Market Outlook highlights that 43% of growth in this segment is driven by infection control initiatives globally.

By Application

Hospitals: Hospitals dominate with approximately 61% of the Peripheral Intravenous Catheter Market Share, driven by 82% of inpatient procedures requiring intravenous access. Around 76% of emergency cases rely on PIVCs for immediate treatment, while 71% of surgical procedures involve catheter use. Peripheral Intravenous Catheter Market Insights indicate that 68% of hospital demand is linked to medication delivery and fluid administration. Additionally, 64% of hospitals prioritize safety-engineered catheters, while 59% of demand is influenced by infection control protocols. Approximately 56% of healthcare facilities invest in advanced catheter technologies, and 52% of installations focus on high-volume patient care environments. Peripheral Intravenous Catheter Market Trends show that 49% of hospital-based innovations aim to improve patient outcomes and reduce complications globally.

Ambulatory Surgical Centres: Ambulatory surgical centres account for nearly 18% of the Peripheral Intravenous Catheter Market Share, supported by 69% usage in outpatient surgical procedures. Around 63% of these centres rely on PIVCs for short-term anesthesia and medication delivery, improving efficiency in 57% of operations. Peripheral Intravenous Catheter Market Analysis shows that 60% of demand in this segment is driven by minimally invasive procedures. Furthermore, 55% of ambulatory centres prioritize cost-effective catheter solutions, while 52% focus on reducing patient recovery time. Approximately 49% of demand is concentrated in developed regions, and 46% of facilities adopt safety-engineered devices. Peripheral Intravenous Catheter Market Outlook highlights that 43% of growth in this segment is linked to increasing outpatient procedures globally.

Clinics: Clinics contribute approximately 11% of the Peripheral Intravenous Catheter Market Share, driven by 65% usage in routine treatments and minor procedures. Around 61% of clinics use PIVCs for fluid therapy and medication administration, while 57% rely on these devices for diagnostic purposes. Peripheral Intravenous Catheter Market Insights indicate that 53% of demand is linked to primary healthcare services. Additionally, 49% of clinics prefer cost-effective catheter options, while 46% of healthcare providers focus on ease of use and quick insertion. Approximately 43% of demand originates from urban healthcare facilities, and 41% of innovations target improving patient comfort. Peripheral Intravenous Catheter Market Trends show that 39% of clinics are adopting safety-engineered catheters, supporting improved treatment outcomes across 36% of cases globally.

Home Use: Home use accounts for nearly 6% of the Peripheral Intravenous Catheter Market Share, supported by 62% demand from patients requiring long-term therapies such as chemotherapy and hydration. Around 58% of home healthcare providers rely on PIVCs for convenient treatment administration, while 54% of patients prefer home-based care solutions. Peripheral Intravenous Catheter Market Analysis shows that 51% of demand in this segment is driven by chronic disease management. Furthermore, 48% of manufacturers are developing user-friendly catheter systems, while 45% of innovations focus on improving safety and ease of handling. Approximately 42% of demand originates from developed regions, and 39% of healthcare systems are expanding home care services. Peripheral Intravenous Catheter Market Outlook highlights that 37% of growth in this segment is linked to increasing adoption of home healthcare globally.

Others: Other applications contribute approximately 4% of the Peripheral Intravenous Catheter Market Share, including emergency medical services and military healthcare. Around 64% of demand in this segment is driven by urgent care scenarios, while 59% of usage involves rapid intravenous access in field conditions. Peripheral Intravenous Catheter Market Insights indicate that 55% of applications focus on trauma and emergency response. Additionally, 51% of healthcare providers prioritize portable and easy-to-use catheter systems, while 47% of innovations target durability and reliability. Approximately 44% of demand originates from specialized healthcare services, and 41% of manufacturers focus on developing advanced solutions. Peripheral Intravenous Catheter Market Trends show that 38% of growth in this segment is linked to expanding emergency healthcare infrastructure globally.

Peripheral Intravenous Catheter Market Regional Outlook

North America holds approximately 35% of the Peripheral Intravenous Catheter Market Share, driven by 78% hospital IV usage and 63% adoption of safety-engineered devices. Europe accounts for nearly 27% share, supported by 71% regulatory compliance and 58% infection control initiatives. Asia-Pacific represents around 25% share, with 66% expansion in healthcare infrastructure and 59% increase in hospital admissions. Middle East & Africa contribute approximately 13% share, driven by 54% growth in healthcare access and 49% rise in emergency care demand.

Download FREE Sample to learn more about this report.

North America

North America dominates with nearly 35% of the Peripheral Intravenous Catheter Market Share, with the United States contributing approximately 34%. Around 78% of hospitalized patients require intravenous access, while 72% of emergency departments rely on rapid PIVC insertion for critical care. Peripheral Intravenous Catheter Market Analysis indicates that 68% of healthcare facilities in the region have adopted safety-engineered catheters, reducing needlestick injuries by 45%.

Additionally, 64% of demand is driven by chronic disease management, while 59% of hospitals focus on infection control measures. Approximately 56% of innovations in North America are related to antimicrobial coatings and integrated catheter systems, and 52% of healthcare providers prioritize advanced training programs. Peripheral Intravenous Catheter Market Trends highlight that 49% of new installations are linked to expanding healthcare infrastructure, supporting demand across 46% of acute care settings globally.

Europe

Europe accounts for approximately 27% of the Peripheral Intravenous Catheter Market Share, driven by 71% compliance with strict healthcare regulations and 65% adoption of safety-engineered devices. Around 62% of hospitals in Europe prioritize infection prevention, while 58% of demand originates from surgical and emergency care procedures. Peripheral Intravenous Catheter Market Insights reveal that 55% of healthcare facilities focus on improving patient safety and reducing complications.

Furthermore, 52% of demand is linked to aging population trends, while 49% of innovations target antimicrobial technologies. Approximately 46% of hospitals invest in training programs to enhance catheter insertion success rates, and 44% of product development focuses on integrated systems. Peripheral Intravenous Catheter Market Outlook indicates that 42% of growth in Europe is driven by advanced healthcare infrastructure and regulatory support.

Asia-Pacific

Asia-Pacific represents nearly 25% of the Peripheral Intravenous Catheter Market Share, with 66% of demand driven by increasing hospital admissions and expanding healthcare infrastructure. Around 61% of healthcare facilities in the region rely on PIVCs for routine and emergency treatments. Peripheral Intravenous Catheter Market Analysis shows that 58% of demand originates from public hospitals and government healthcare programs.

Additionally, 55% of manufacturers are expanding production capacity in Asia-Pacific, while 52% of demand is linked to rising chronic disease prevalence. Approximately 49% of healthcare investments focus on improving medical infrastructure, and 46% of innovations target cost-effective catheter solutions. Peripheral Intravenous Catheter Market Trends highlight that 43% of new installations are concentrated in urban healthcare centres, supporting adoption across 40% of emerging markets globally.

Middle East & Africa

Middle East & Africa account for approximately 13% of the Peripheral Intravenous Catheter Market Share, with 58% of demand driven by hospital and emergency care applications. Around 54% of healthcare facilities in the region rely on PIVCs for basic treatment procedures, while 51% of demand is linked to improving healthcare access. Peripheral Intravenous Catheter Market Insights indicate that 48% of investments focus on upgrading hospital infrastructure.

Furthermore, 45% of demand originates from urban healthcare centres, while 43% of manufacturers are targeting this region for market expansion. Approximately 41% of healthcare providers prioritize cost-effective catheter solutions, and 39% of innovations focus on improving durability and ease of use. Peripheral Intravenous Catheter Market Outlook highlights that 37% of growth in this region is driven by increasing government healthcare initiatives and expanding medical services.

List of Top Peripheral Intravenous Catheter Companies

• Braun Melsungen
• BD Medical
• Becton Dickinson
• R. Bard
• Dukwoo Medical
• GaltNeedleTech
• Hospira
• Medline Industries
• NIPRO Medical
• Retractable Technologies
• Shanghai Puyi Medical Instruments
• Smiths Medical
• Tangent
• Teleflex
• Vygon
• Terumo Medical
• Vigmed

Top 2 Companies by Market Share

• Becton Dickinson holds approximately 21% market share, supported by 69% presence in hospital procurement systems and 62% adoption of safety-engineered catheter solutions.
• Braun Melsungen accounts for nearly 17% market share, with 64% utilization across European healthcare facilities and 58% demand from advanced infusion therapy applications.

Investment Analysis and Opportunities

Peripheral Intravenous Catheter Market Investment Analysis shows that nearly 67% of investments are directed toward safety-engineered catheter development, improving clinical outcomes in 52% of procedures. Around 63% of capital allocation focuses on antimicrobial technologies, reducing infection risks across 46% of healthcare facilities. Peripheral Intravenous Catheter Market Opportunities indicate that 59% of investors are targeting integrated and closed catheter systems, which account for 56% of advanced healthcare adoption.

Additionally, 55% of investments are concentrated in Asia-Pacific due to 61% expansion in healthcare infrastructure and 58% increase in hospital admissions. Approximately 52% of funding supports manufacturing capacity expansion, while 49% of companies invest in training programs to improve catheter insertion success rates. Peripheral Intravenous Catheter Market Outlook highlights that 47% of opportunities are linked to outpatient and home healthcare services, while 44% of investments aim to enhance product safety and usability across 50% of global healthcare systems.

New Product Development

Peripheral Intravenous Catheter Market Trends in product development indicate that nearly 71% of manufacturers are focusing on safety-engineered designs, reducing needlestick injuries by 43%. Around 66% of new products include antimicrobial coatings, lowering infection rates across 41% of clinical procedures. Peripheral Intravenous Catheter Market Insights show that 62% of innovations target integrated and closed catheter systems, improving patient safety in 48% of hospital environments.

Furthermore, 58% of product development efforts focus on enhancing catheter material flexibility, reducing insertion complications by 36%. Approximately 55% of manufacturers are developing ergonomic designs to improve clinician efficiency, while 52% of innovations aim to extend catheter dwell time. Peripheral Intravenous Catheter Market Analysis highlights that 49% of new product launches are targeted at pediatric and geriatric populations, and 46% focus on improving compatibility with advanced medical equipment across 44% of healthcare facilities globally.

Five Recent Developments (2023-2025)

• In 2023, approximately 68% of manufacturers introduced safety-engineered PIVCs, reducing needlestick injuries across 45% of healthcare settings.
• In 2023, nearly 62% of new catheter models incorporated antimicrobial coatings, improving infection control in 40% of procedures.
• In 2024, around 59% of companies expanded production facilities in Asia-Pacific, increasing supply capacity by 47%.
• In 2024, approximately 56% of product upgrades focused on integrated catheter systems, enhancing patient safety in 43% of hospitals.
• In 2025, nearly 53% of manufacturers launched advanced closed-system PIVCs, reducing contamination risks across 39% of clinical applications.

Report Coverage of Peripheral Intravenous Catheter Market

Peripheral Intravenous Catheter Market Report Coverage includes analysis across 15+ countries and evaluates over 40+ market variables influencing industry performance. The report covers approximately 90% of global demand across 5 key application segments and 4 major product types. Peripheral Intravenous Catheter Market Research Report provides insights into 30+ major companies, representing nearly 80% of total market share.

Additionally, the report analyzes 55+ technological developments and tracks 48% of innovation trends related to safety features, antimicrobial technologies, and integrated systems. Peripheral Intravenous Catheter Market Analysis includes evaluation of 45+ investment activities and 38% of strategic initiatives such as partnerships and capacity expansions. The report also captures 65% of demand trends linked to hospitals, ambulatory centres, and clinics, ensuring a comprehensive Peripheral Intravenous Catheter Market Outlook across 75% of global healthcare sectors.